In a boost to Japan and green tea lovers around the world, a new study has revealed that the componenet ‘catechins’ in green tea may help reduce development of prostate cancer in men.
Led by Indian-origin researcher Nagi Kumar of Moffitt Cancer Center, the team of researchers found that it is helpful in men who have premalignant lesions and prone to prostate cancer. It could be another reason why prostate cancer is less in asian countries where 20 percent of green tea is consumed as a daily and casual beverage, Japan topping the list.
However, the risk of prostate cancer is visibly on the rise among those Asians who migrate to the US and in turn abandon their original dietary habits, noted the researchers.
In their experiments, the researchers found that catechins inhibit cancer cell growth, motility and invasion, and even cause the stimulation of cancer cell death.
Even in animal models, green tea catechins were found to have prevented and reduced tumor growth. The researchers attribute all the credit to Epigallocatechin-3-gallate (EGCG), an abundant catechin found in green tea.
Their study has been published in the journal Cancer Prevention Research.
Moffitt Cancer Center has been contributing to cancer research for long and some of their recent findings have opened new areas for research.
Their recent study on side effects of cancer therapies showed that genetic factors and other characteristics might make prostate cancer patients more likely to experience hot flashes during and after therapy.
More than 25 percent of prostate cancer patients report that hot flashes are the most distressing side effect of ADT and they remain for years after ADT is complete.